Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database-Reference-Cited by-同舟云学术

Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database

Published:2018-09 Issue:9 Volume:40 Page:1522-1537
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Fisher Maxine D.,Fernandes Ancilla W.,Olufade Temitope O.,Miller Paul J.,Walker Mark S.,Fenton Moon

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2018

2. State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013;Denaro;Oncology,2014

3. Recent advances in head and neck cancer;Haddad;N Engl J Med,2008

4. National Comprehensive Cancer Network (NCCN). NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017;Adelstein;J Natl Compr Canc Netw,2017

5. Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study;Guigay;Ann Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment for Locoregionally Recurrent Head and Neck Cancers;Korean Journal of Otorhinolaryngology-Head and Neck Surgery;2022-03-21

2. Factors that Influence 2-Year Progression-Free Survival Among Head and Neck Cancer Patients;Journal of Epidemiology and Global Health;2021-11-30

3. Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany;Journal of Cancer Research and Clinical Oncology;2021-01-31

4. Recurrent squamous cell carcinoma of head and neck: results of treatment in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine in 2012–2016;Head and Neck Tumors (HNT);2020-04-11

5. Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents;Journal of Medical Economics;2019-10-18